Literature DB >> 16606417

Photolocalized purpura during ciprofloxacin therapy.

Francisco Urbina1, Moema Barrios, Emilio Sudy.   

Abstract

Photosensitivity reactions reported with ciprofloxacin mimic those of sunburn, with erythema and edema in the milder forms, and painful blistering with subsequent peeling when severe. Purpuric eruptions during treatment with ciprofloxacin have been rarely reported. We describe a 30-year-old man who was given a 15-day course with ciprofloxacin 500 mg twice a day for a prostatitis. Coinciding with sun exposure, he developed a purpuric, pruriginous eruption on his lower extremities, consisting of erythematous, petechial lesions located on the anterior aspect of his thighs and legs, clearly delimited by his bathing suit. The lesions cleared completely after the discontinuation of the drug and treatment with topical clobetasol. The acute reaction observed in our patient differed from a classical sunburn, consisting of confluent petechias, strictly limited to sunlight-exposed areas, and accompanied by pruritus. Photoexposed purpuric eruptions should be considered as another side effect of ciprofloxacin therapy in addition to phosensitivity rashes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606417     DOI: 10.1111/j.1600-0781.2006.00210.x

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  3 in total

Review 1.  Drug-induced photosensitivity: culprit drugs, management and prevention.

Authors:  Aaron M Drucker; Cheryl F Rosen
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

2.  Doxycycline-Associated Dual Cutaneous Adverse Reaction to the Drug (CARD): Case Report of Concurrent Photosensitivity and Morbilliform Exanthem to Doxycycline.

Authors:  Joanne S Jacob; Philip R Cohen
Journal:  Cureus       Date:  2020-11-18

3.  Rosuvastatin induced photolocalized purpura.

Authors:  Marwa Thabouti; Nadia Gahriani Fetoui; Linda Manaa; Jacem Rouatbi; Badreddine Sriha; Chaker Ben Salem; Mohamed Denguezli
Journal:  Clin Case Rep       Date:  2022-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.